Basic Information
| LncRNA/CircRNA Name | ADAMTS9-AS1 |
| Synonyms | NA |
| Region | GRCh38_3:64561322-64592757 |
| Ensemble | ENSG00000241158 |
| Refseq | NR_110150 |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | prostate cancer |
| ICD-0-3 | C61.9 |
| Methods | qRT-PCR |
| Sample | PCa tissues,cell lines |
| Expression Pattern | differential expression |
| Function Description | ADAMTS9-AS1 significantly influences tumor cell growth and proliferation.In addition, ADAMTS9-AS1 functioned as ceRNA, effectively becoming a sponge for hsa-miR-96 and modulating the expression of PRDM16. |
| Pubmed ID | 32153626 |
| Year | 2019 |
| Title | Data mining and expression analysis of differential lncRNA ADAMTS9-AS1 in prostate cancer |
External Links
| Links for ADAMTS9-AS1 | GenBank HGNC NONCODE |
| Links for prostate cancer | OMIM COSMIC |